Objective: This study aims to elucidate the long-term benefit of newborn screening (NBS) for individuals with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiency, inherited metabolic diseases included in NBS programs worldwide.

Methods: German national multicenter study of individuals with confirmed LCHAD/MTP deficiency identified by NBS between 1999 and 2020 or selective metabolic screening. Analyses focused on NBS results, confirmatory diagnostics, and long-term clinical outcomes.

Results: Sixty-seven individuals with LCHAD/MTP deficiency were included in the study, thereof 54 identified by NBS. All screened individuals with LCHAD deficiency survived, but four with MTP deficiency (14.8%) died during the study period. Despite NBS and early treatment neonatal decompensations (28%), symptomatic disease course (94%), later metabolic decompensations (80%), cardiomyopathy (28%), myopathy (82%), hepatopathy (32%), retinopathy (17%), and/or neuropathy (22%) occurred. Hospitalization rates were high (up to a mean of 2.4 times/year). Disease courses in screened individuals with LCHAD and MTP deficiency were similar except for neuropathy, occurring earlier in individuals with MTP deficiency (median 3.9 vs. 11.4 years; p = 0.0447). Achievement of dietary goals decreased with age, from 75% in the first year of life to 12% at age 10, and consensus group recommendations on dietary management were often not achieved.

Interpretation: While NBS and early treatment result in improved (neonatal) survival, they cannot reliably prevent long-term morbidity in screened individuals with LCHAD/MTP deficiency, highlighting the urgent need of better therapeutic strategies and the development of disease course-altering treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021608PMC
http://dx.doi.org/10.1002/acn3.52002DOI Listing

Publication Analysis

Top Keywords

mtp deficiency
16
lchad/mtp deficiency
12
screened individuals
12
deficiency
8
identified nbs
8
individuals lchad/mtp
8
individuals lchad
8
nbs early
8
early treatment
8
nbs
7

Similar Publications

Microsomal triglyceride transfer protein (MTP) plays crucial roles in the assembly and secretion of apolipoprotein B-containing lipoproteins and loss of function MTP variants are associated with abetalipoproteinemia, a disease characterized by the absence of these lipoproteins. MTP is a heterodimeric protein of two subunits, MTP and protein disulfide isomerase (PDI). In this study, we report a proband with abetalipoproteinemia who was monitored annually over a period of ten years in her third decade and had very low plasma lipids and undetectable apoB-containing lipoproteins.

View Article and Find Full Text PDF

ERICH4 is not involved in the assembly and secretion of intestinal lipoproteins.

Atherosclerosis

December 2024

Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address:

Background And Aims: The small intestine plays a central role in lipid metabolism, most notably the uptake of dietary fats that are packaged into chylomicrons and secreted into the circulation for utilisation by peripheral tissues. While microsomal triglyceride transfer protein (MTP) is known to play a key role in this pathway, the intracellular assembly, trafficking, and secretion of chylomicrons is incompletely understood.

Methods And Results: Using human transcriptome datasets to find genes co-regulated with MTTP, we identified ERICH4 as a top hit.

View Article and Find Full Text PDF
Article Synopsis
  • - Abetalipoproteinemia (ABL) is a rare genetic disorder characterized by the absence of certain lipoproteins due to a defective triglyceride transfer protein, impacting the retina and leading to vision problems, including conditions resembling retinitis pigmentosa.
  • - Multimodal retinal imaging was conducted on two ABL patients, revealing significant eye changes like choroidal neovascularization and deposits in the retina, alongside a range of vision loss.
  • - The study suggests that mutations in the MTTP gene within the retina may contribute to ABL-related eye diseases, highlighting the importance of ongoing eye care for affected individuals, particularly to manage treatable conditions like choroidal neovascularization.
View Article and Find Full Text PDF

Mitochondrial trifunctional protein (MTP) deficiency is a fatty acid oxidation disorder associated with a spectrum of phenotypes. Patients with high residual enzyme activity tend to have milder phenotypes, and recently, fever-induced episodic myopathy was reported in association with a thermosensitive form of MTP deficiency. We report a 10-year-old male with recurrent episodes of acute flaccid paralysis involving upper and lower extremities in association with bulbar muscle weakness in the context of febrile illness, a phenotype reminiscent of recurrent periodic paralysis.

View Article and Find Full Text PDF

High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population.

J Clin Lipidol

August 2024

Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute, Montréal, Québec, Canada (Drs Guay, Paquette, Gosse, Poulin, and Baass); Department of Medicine, Divisions of Experimental Medicine and Medical Biochemistry, McGill University, Montréal, Québec, Canada (Dr Baass). Electronic address:

Article Synopsis
  • * Patients exhibit a range of symptoms, including neurological, hematological, and gastrointestinal issues, due to the lack of certain lipoproteins.
  • * The report highlights four cases from a specific French-Canadian population, showing a higher-than-expected prevalence of a particular MTTP mutation, recommending early diagnosis and potential screening in the community.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!